R-L: Permanent Secretary, Rivers State Primary Health Board, Dr. Agba Harry; SPDC External Relations Manager, Evans Krukrubo; General Manager External Relations, Igo Weli; Rivers State Commissioner for Health, Professor Princewill Anthony Chike; Permanent Secretary Rivers State Ministry of Health, with Shell Dr. Ndidi Uchey; Dr. Akinwunmi Fajola;  Dr. Ufuoma Ovwigho; Dr. Nsikak Abasi Ntia; and Dr. Ibrahim Yusuf, at the handover of medical equipment to boost the fight against COVID-19 at the Rivers State Holding Centre, Eleme.

SPDC’s Managing Director and Country Chair, Shell Companies in Nigeria, Osagie Okunbor, disclosed this on Tuesday while presenting hospital and medical equipment to Rivers State Government in Port Harcourt where the company is headquartered. Four of the vehicles, he said, went to the government of Lagos State which has the highest number of confirmed COVID-19 cases and the other four, including an ambulance, were given to Rivers State.

Represented by the SPDC’s General Manager External Relations, Igo Weli, Okunbor said the multimillion naira donations would reposition three tertiary medical facilities in the state to test, treat and generally manage any COVID-19 cases in the Niger Delta in the event of an outbreak.

“Shell’s interventions will enhance the clinical capacities and capabilities within Rivers State in particular with focus on the Eleme General Hospital, the Rivers State University Teaching Hospital (RSUTH), and the University of Port Harcourt Teaching Hospital (UPTH),” Okunbor said, adding thatSPDC and its partners areworking with the Rivers State Ministry of Health and Nigeria Centre for Disease Control to ensure laboratories at the RSUTH and UPTH attain capacity to be used to conduct approved tests. “This will cut the turn-around time for the receipt of tests results, with tests currently carried out atIrua, Edo State, for Rivers and other states in the Niger Delta.”

According to Okunbor, Shell is making direct interventions to enhance clinical capacities and capabilities across locations where it currently has operations in Nigeria, including Abia, Bayelsa, Delta, Imo, Lagos and Ogun States.

The Rivers State Commissioner for Health, Prof. Princewill Chike, who took delivery of the equipment described the Shell intervention as timely and critical to the success of readying the state to manage any disease outbreak in Rivers State. “We appreciate you, Shell, and your partners. You have, again, shown leadership. You have proved that you are different. Shell representatives in the state’s technical monitoring groups are always on time and they are a reference point for others.”

The commissioner said the state was in a hurry to be fully ready for any outbreak of the coronavirus disease.

“ This pandemic is quite serious. This is why Rivers State has been on an alert phase since the COVID-19 outbreak. This is no time to blame anybody but for all hands to be on deck,” he said.”

The donated equipment included defibrillators, ventilators, stretchers, swabs, personal protection equipment (PPEs), and a 150kva generator for the Rivers State COVID-19 holding centre in Eleme area of Rivers State.

Bamidele Odugbesan
Media Relations Manager
April 9, 2020
Softphone: +234 807 022 8045

Cautionary note

The companies in which Royal Dutch Shell plc directly and indirectly owns investments are separate entities. In this announcement “Shell”, “ Shell group” and “Royal Dutch Shell” are sometimes used for convenience where references are made to Royal Dutch Shell plc and its subsidiaries in general. Likewise, the words “we”, “us” and “ our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies. ‘‘Subsidiaries’’, “Shell subsidiaries” and “Shell companies” as used in this announcement refer to companies over which Royal Dutch Shell plc either directly or indirectly has control. Companies over which Shell has joint control are generally referred to “joint ventures” and companies over which Shell has significant influence but neither control nor joint control are referred to as “associates”. In this announcement, joint ventures and associates may also be referred to as “equity-accounted investments”. The term “Shell interest” is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in a venture, partnership or company, after exclusion of all third-party interest.

This announcement contains forward-looking statements concerning the financial condition, results of operations and businesses of Royal Dutch Shell. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management’s current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Royal Dutch Shell to market risks and statements expressing management’s expectations, beliefs, estimates, forecasts, projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as ‘‘anticipate’’, ‘‘believe’’, ‘‘could’’, ‘‘estimate’’ , ‘‘expect’’, ‘‘goals’’, ‘‘intend’’, ‘‘may’’, ‘‘objectives’’, ‘‘ outlook’’, ‘‘plan’’, ‘‘probably’’, ‘‘project’’, ‘‘risks’’, “ schedule”, ‘‘seek’’, ‘‘should’’, ‘‘target’’, ‘‘will’’ and similar terms and phrases. There are a number of factors that could affect the future operations of Royal Dutch Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this announcement, including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shell’s products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets, and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation of the terms of contracts with governmental entities, delays or advancements in the approval of projects and delays in the reimbursement for shared costs; and (m) changes in trading conditions. All forward-looking statements contained in this announcement are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Royal Dutch Shell’s 20-F for the year ended December 31, 2019 (available at and These risk factors also expressly qualify all forward-looking statements contained in this announcement and should be considered by the reader. Each forward-looking statement speaks only as of the date of this announcement, April 9, 2020. Neither Royal Dutch Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this announcement.

We may have used certain terms, such as resources, in this announcement that United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC. U.S. Investors are urged to consider closely the disclosure in our Form 20-F, File No 1-32575, available on the SEC website You can also obtain these forms from the SEC by calling 1-800-SEC-0330.